Chinese Customers Can Now Order NVIDIA's Vera CPUs: Report

NVIDIA shares were up 0.62% to $206.13 premarket as the company pitches its Vera AI data center CPU to Chinese customers, with availability potentially starting as soon as August. The article highlights continued China growth prospects despite U.S. export controls that have stalled H200 shipments, while technicals remain constructive with NVDA 5.9% above its 100-day SMA and earnings due Aug. 26, 2026. Analysts expect EPS of $2.06 on $91.70 billion in revenue, and the stock carries a consensus Buy with a $323.83 average target.

Analysis

The real upside here is not the near-term CPU revenue itself, but the signaling effect: NVIDIA is showing it can keep monetizing China through adjacent silicon even when flagship accelerators are constrained. That matters because Chinese hyperscalers will likely treat a compliant CPU as a bridge product for AI infrastructure refreshes, preserving NVIDIA’s software pull-through and delaying share gains for domestic challengers. The second-order winner is likely NVIDIA’s broader platform stack; the CPU can deepen lock-in at the system level even if GPU volumes remain capped.

The key competitive risk is that this could accelerate a “good enough” substitution cycle in China, but not necessarily in NVIDIA’s favor. If buyers are forced to redesign around CPUs instead of accelerators, domestic vendors and alternate architectures get more time to standardize, and software migration costs can gradually shift bargaining power away from NVIDIA over the next 6-18 months. In that sense, Vera is both a revenue opportunity and a defensive move that may cap the pace of margin expansion if it requires more channel incentives or localized support.

The setup looks tactically constructive but not yet trend-confirming. With momentum still neutral and the stock sitting in a well-defined band, the next catalyst is less the product announcement and more order conversion or management commentary on China contribution at the next earnings print. The market is likely overestimating how quickly this becomes material revenue, but underestimating how valuable it is as an option on future China TAM if export restrictions remain static.

The main downside tail is policy reversal: if U.S. controls tighten further or Chinese buyers face procurement scrutiny, the entire China CPU thesis can stall before meaningful revenue is recognized. Conversely, if testing proves seamless, this could become a slow-burn positive over multiple quarters rather than a one-week trade.

Key Decisions for Investors

• Buy NVDA on dips toward the 50-day moving average with a 3-6 month horizon; risk/reward favors a rebound back toward the 20-day band if China CPU orders convert, with support near the 100-day SMA limiting downside.
• Use a call spread in NVDA (e.g., 3-4 month tenor, strikes centered above current resistance) to express upside from China optionality while limiting premium burn if the stock remains range-bound.
• Pair trade: long NVDA / short a basket of U.S. AI hardware suppliers more exposed to short-cycle demand, since Vera extends platform lock-in while smaller names face more direct pricing pressure if Chinese buyers delay GPU refreshes.
• For event-driven positioning, reduce risk into the next earnings window if the stock fails to reclaim the 20-day moving average; the trade thesis depends on adoption evidence, not just product headlines.